Benjamin Graham fit · Inversión deep-value defensiva
Is Cytek Biosciences, Inc. Common Stock (CTKB) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
20/100
FNo encaja
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a CTKB
P/E ≤ 15
clave—
P/B ≤ 1.5
clave0.0x
Current ratio ≥ 2
5.2x
Debt / Equity ≤ 1
0.0x
Cómo se valora CTKB en otras estrategias
Datos financieros en vivo
Cap. mercado
$517.86M
PER (TTM)
-
ROIC (TTM)
-11.42%
Margen bruto
51.7%
Otros análisis Benjamin Graham
Preguntas frecuentes
What is CTKB's Benjamin Graham fit score?
CTKB scores 20/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own CTKB?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends CTKB.
How often is this score updated?
CTKB's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende CTKB personalmente.